View Older Stories View More Recent Stories
-
Roth Capital Starts Charles & Colvard (CTHR) at Buy
-
Analysts split on Tesla 2019 delivery promises
-
ROTH Capital Partners to Host 5th Annual ROTH London Conference on June 17- 19, 2019 in London, UK
-
Charles & Colvard, Ltd. Announces Closing of Public Offering
-
Roth Capital Upgrades CECO Environmental (CECE) to Buy
-
Roth Capital Starts Gold Resource Corp (GORO) at Buy
-
Ameresco to Participate at Upcoming Conference
-
Pre-Open Movers 06/10: (PRVB) (DATA) (TLRY) Higher; (INSY) (RWLK) (ONCE) (more...)
-
Roth Capital Upgrades Tesla (TSLA) to Buy
-
Roth Capital Starts CRISPR Therapeutics (CRSP) at Buy
-
eGain to Participate in ROTH London Conference
-
Roth Capital Starts Intellia Therapeutics (NTLA) at Neutral
-
Diamondback Energy (FANG) PT Lowered to $150 at Roth Capital
-
Charles & Colvard Ltd (CTHR) Prices 6.25M Public Offering of Common Stock at $1.60/Share
-
Charles & Colvard Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Fate Therapeutics (FATE) at Neutral
-
Charles & Colvard Provides Fourth Fiscal Quarter 2019 and Full-Year Financial Guidance (Press Release Updated to Include Correct Links to SEC Filings)
-
Charles & Colvard Provides Fourth Fiscal Quarter 2019 and Full-Year Financial Guidance
-
Charles & Colvard Ltd (CTHR) Plans Offering of Common Stock
-
Charles & Colvard Announces Proposed Offering of Common Stock
-
SMG Industries Announces the Signing of a Definitive Agreement to Acquire Trinity Services LLC
-
Roth Capital Starts KushCo Holdings, Inc (KSHB) at Buy
-
Optimizerx Corporation (OPRX) Prices 1.54M Shares at $13
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
OptimizeRx Announces Pricing of Public Offering of Common Stock
-
Rx3 Ventures, Co-Founded by Aaron Rodgers, Closes on Over $50 Million to Back Growing Consumer Brands
-
Roth Capital Starts Allogene (ALLO) at Neutral
-
NetworkNewsBreaks – InterDigital, Inc. (NASDAQ: IDCC) Closes $400M Senior Convertible Notes Offering
-
NetworkNewsBreaks – Prescient Therapeutics Ltd. (ASX: PTX) Completes $7 Million AUD PIPE
-
NetworkNewsBreaks – The Lovesac Company (NASDAQ: LOVE) Secures $103.5M Through Underwritten Public Offering
-
UPDATE: MaxLinear (MXL) PT Lowered to $23 at Roth Capital
-
Greenlane to Participate at Upcoming Conferences
-
Greenlane to Participate at Upcoming Conferences
-
Greenlane to Participate at Upcoming Conferences
-
Roth Capital Reiterates Buy Rating on Standard Lithium Ltd (STLHF)
-
Digital Turbine (APPS) PT Raised to $5 at Roth Capital
-
Roth Capital Downgrades Cypress Semi (CY) to Neutral Following Acquisition Bid
-
The Joint Corp (JYNT) PT Raised to $23 at Roth Capital
-
Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer
-
Roth Capital Reiterates Buy Rating on Green Thumb Industries (GTBIF)
-
Renewable Energy Group to Participate at Upcoming Conferences
-
Roth Capital Starts TCR2 Therapeutics (TCRR) at Neutral
-
Roth Capital Starts Adaptimmune Therapeutics plc (ADAP) at Buy
-
UPDATE: Roth Capital Upgrades Himax Technologies (HIMX) to Buy
-
Roth Capital Positive on Melco (MLCO) Crown Share Purchase
-
Former Roth Capital Partners Investment Banker Joins Cannabis Investment Firm Archytas Ventures as a Vice President
-
Roth Capital Starts Marker Therapeutics (MRKR) at Buy
-
Roth Capital Starts Atara Biotherapeutics (ATRA) at Buy
-
Roth Capital Transfers Coverage on Kalvista Pharmaceuticals Inc (KALV) at Buy
-
UPDATE: Roth Capital Starts Corvus Pharmaceuticals (CRVS) at Buy

